Cargando…
ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991342/ http://dx.doi.org/10.1186/2051-1426-1-S1-P42 |
_version_ | 1782312418800566272 |
---|---|
author | Mangsbo, Sara M Broos, Sissela Gustafsson, Erika Furebring, Christina Veitonmäki, Niina Dahlen, Eva Norlen, Per Lindstedt, Malin Tötterman, Thomas Ellmark, Peter |
author_facet | Mangsbo, Sara M Broos, Sissela Gustafsson, Erika Furebring, Christina Veitonmäki, Niina Dahlen, Eva Norlen, Per Lindstedt, Malin Tötterman, Thomas Ellmark, Peter |
author_sort | Mangsbo, Sara M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3991342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39913422014-05-05 ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer Mangsbo, Sara M Broos, Sissela Gustafsson, Erika Furebring, Christina Veitonmäki, Niina Dahlen, Eva Norlen, Per Lindstedt, Malin Tötterman, Thomas Ellmark, Peter J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991342/ http://dx.doi.org/10.1186/2051-1426-1-S1-P42 Text en Copyright © 2013 Mangsbo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Mangsbo, Sara M Broos, Sissela Gustafsson, Erika Furebring, Christina Veitonmäki, Niina Dahlen, Eva Norlen, Per Lindstedt, Malin Tötterman, Thomas Ellmark, Peter ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title | ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title_full | ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title_fullStr | ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title_full_unstemmed | ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title_short | ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer |
title_sort | adc-1013, an agonistic cd40 antibody optimized for local immunotherapy of cancer |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991342/ http://dx.doi.org/10.1186/2051-1426-1-S1-P42 |
work_keys_str_mv | AT mangsbosaram adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT broossissela adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT gustafssonerika adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT furebringchristina adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT veitonmakiniina adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT dahleneva adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT norlenper adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT lindstedtmalin adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT tottermanthomas adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer AT ellmarkpeter adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer |